This cluster randomized trial assesses whether the receipt of targeted feedback based on artificial intelligence (AI)-enabled medical record abstraction can improve physician compliance with the Centers for Medicare & Medicaid Services Severe Sepsis and Septic Shock Management Bundle.
This qualitative study examines and characterizes the needs, expectations, and perceptions of Nigerian children and adolescents with upper limb differences regarding upper limb prostheses within their sociocultural and daily environments.
This cross-sectional study examines the financial, logistical, and psychosocial factors underlying use of health care between male and female patients with atrial fibrillation.
This cohort study evaluates the association between severity of chronic kidney disease and mortality, kidney replacement therapy, and length of stay after intensive care unit (ICU) admission among Canadian adults.
This cohort study examines which features of naturalistic speech are associated with concurrent variation in symptom severity in adult patients with schizophrenia spectrum disorders in Dutch and US samples.
This cohort study examines the association of diet quality with dementia risk across biomarkers for Alzheimer disease pathology and neurodegenerative and glial processes in older adults without dementia in Sweden.
Priority Health is partnering with Garner Health to steer members to high-quality physicians and reduce healthcare costs for employers. The post New Partnership Aims to Lower Out-of-Pocket Costs, Even Eliminate Them In Some Cases appeared first on MedCity News .
Hundreds of women with aggressive cervical cancer are to be offered a new immunotherapy on the NHS, which could help more women survive and stay cancer-free in the long-term. Pembrolizumab – which experts describe as being able to ‘take the handbrake off the body’s immune system’ to target cancer – will now offer a new […]
Women’s health platform Xella Health launched with a $499-per-year membership. The platform provides women the kind of connected healthcare that has typically only been available through expensive concierge medicine, said CEO Kelly Lacob. The post Xella Health Emerges from Stealth to Give Women Answers the Healthcare System Hasn’t appeared first on MedCity News .
Drug Trials Snapshots: breaking down the what, how and why. Drug Trials Snapshots is part of an overall FDA effort to make demographic data more available and transparent.
New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults mcarmody Wed, 06/24/2026 - 17:26 Press release New Standards of Care in Overweight and Obesity Section: Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ARLINGTON, Va. June 29, 2026 Today, the Obesity Association, a division of the American Diabetes Association ® (the association), announced the next section in the Standards of Care in Overweight and Obesity, “ Screening, Diagnosis, Evaluation, and Staging of Obesity in Adults ,” published in Diabetes…
The Food and Drug Administration is advising consumers not to purchase or use PRE-FORMANCE BLACK, a product promoted to boost energy and increase performance on various websites, including Advancedsupps.com, and possibly in some retail stores.
The UK will support Gazan students to take up places at British universities and continue efforts to medically evacuate critically ill children for treatment in the NHS.
The U.S. Food and Drug Administration (FDA) has approved Tryngolza (olezarsen), used with diet, to reduce triglycerides and the risk of acute pancreatitis in adults with severe hypertriglyceridemia.
On June 24, 2026, the Food and Drug Administration approved palbociclib (Ibrance, Pfizer Inc.) in combination with trastuzumab, with or without pertuzumab, and endocrine therapy for the maintenance treatment of adults with HR-positive, HER2-positive locally advanced or metastatic breast cancer follo
In patients with Friedreich ataxia (FA) cardiomyopathy, intravenous administration of AAVrh.10hFXN, an rh.10 serotype cardiotropic adenoassociated virus vector expressing the normal human FXN coding sequence, was well tolerated and showed promise as a potential treatment...